Interventional Agents Safety and Pharmacokinetic Services (IASPS)
Past New Requirement Updated
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $1,500,000 to $3,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services National Institutes of Health (NIH) is forecasting a new requirement for Interventional Agents Safety and Pharmacokinetic Services (IASPS), categorized under Research and Development in Biotechnology. The contract, with an estimated award date of October 1, 2024, appears to focus on research services related to safety assessment and pharmacokinetic analysis of interventional agents, targeting contractors in the biotechnology research and development sector.
While specific award values are not disclosed, the opportunity is classified under NAICS code 541714 and does not have a specific set-aside designation. The primary points of contact for this opportunity are Miranda Adams, a Contract Specialist at NIH, reachable at miranda.adams@nih.gov or +12406695344, and Jeremy Starr from NIH. Potential bidders should note the forecast was posted on December 10, 2025, and may want to engage with these contacts for more detailed information about the scope and requirements of the IASPS contract.
Forecast text
Interventional Agents Safety and Pharmacokinetic Services (IASPS)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast